ISR Share Price

Open 0.62 Change Price %
High 0.62 1 Day -0.02 -3.23
Low 0.57 1 Week 0.04 7.14
Close 0.60 1 Month -0.01 -1.64
Volume 114383 1 Year -0.55 -47.83
52 Week High 1.17
52 Week Low 0.48
ISR Important Levels
Resistance 2 0.65
Resistance 1 0.63
Pivot 0.60
Support 1 0.57
Support 2 0.55
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
NGD 2.78 -10.32%
NGD 2.78 -10.32%
RBY 0.03 -70.00%
PBTH 8.23 0.37%
NAK 1.53 -7.27%
NAK 1.53 -7.27%
PTN 0.42 -4.55%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
CMFO 0.04 -33.33%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
More..

IsoRay, Inc. (AMEX: ISR)

ISR Technical Analysis 2
As on 27th Apr 2017 ISR Share Price closed @ 0.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.67 & Buy for SHORT-TERM with Stoploss of 0.56 we also expect STOCK to react on Following IMPORTANT LEVELS.
ISR Target for April
1st Target up-side 0.69
2nd Target up-side 0.77
3rd Target up-side 0.84
1st Target down-side 0.49
2nd Target down-side 0.41
3rd Target down-side 0.34
ISR Other Details
Segment EQ
Market Capital 20927304.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.isoray.com
ISR Address
ISR
350 Hills Street
Suite 106
Richland, WA 99354
United States
Phone: 509-375-1202
ISR Latest News
Which insiders are buying IsoRay, Inc. (NYSE:ISR)?   Post Analyst   - 28th Apr 17
IsoRay, Inc. to Present at the Planet MicroCap Showcase 2017   Yahoo Finance   - 18th Apr 17
IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative ...   PR Newswire (press release)   - 21st Dec 16
IsoRay, Inc. Announces Date for Fiscal 2017 Annual Meeting and Shareholder ...   PR Newswire (press release)   - 21st Oct 16
IsoRay Boosted By Brain Brachytherapy   Seeking Alpha   - 22nd Jun 16
IsoRay, Inc. Announces Annual Meeting and Shareholder Record Dates   PR Newswire (press release)   - 09th Apr 16
IsoRay Appoints Michael L. Krachon as Vice President of Sales and Marketing ...   PR Newswire (press release)   - 02nd Mar 16
IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15   PR Newswire (press release)   - 14th Jan 16
IsoRay Chairman and CEO Dwight Babcock to Retire   PR Newswire (press release)   - 07th Jan 16
0.62   MarketWatch   - 22nd Dec 09
Interactive Technical Analysis Chart IsoRay, Inc. ( ISR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on IsoRay, Inc.
ISR Business Profile
IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is based in Richland, Washington.